Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1150 MG double-blinded secukinumab
(Cosentyx, COSENTYX)		----[1] 271 💬
2150 MG OPEN-label secukinumab
(Cosentyx, COSENTYX)		----[1] 271 💬
3300 MG double-blinded secukinumab
(Cosentyx, COSENTYX)		----[1] 271 💬
4Cosentyx[1] Secukinumab[1] Secukinumab (Cosentyx, COSENTYX) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[4] 41, 107, 269, 271 💬
5Cosentyx - 150 MG - soluzione iniettabile IN siringa preriempita -USO sottocutaneo - siringa (vetro) 1 ML (150MG/ML)- 2 siringhe preriempite[1] Secukinumab[1] Secukinumab (Cosentyx, COSENTYX) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 107 💬
6Cosentyx 300 MG solution FOR injection IN PRE-filled syringe[1] Secukinumab[1] Secukinumab (Cosentyx, COSENTYX) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 41 💬
7Cosentyx 300MG solution FOR injection IN PRE-filled syringe[1] Secukinumab[1] Secukinumab (Cosentyx, COSENTYX) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 41 💬
8Secukinumab
(Cosentyx, COSENTYX)		[1] Secukinumab[1] Secukinumab (Cosentyx, COSENTYX) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[8] 13, 37, 41, 46, 107, 160, 269, 271 💬
9Secukinumab 150 MG
(Cosentyx, COSENTYX)		[1] Secukinumab[1] Secukinumab (Cosentyx, COSENTYX) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 41 💬
10Secukinumab 150 MG (2 injections PER dose
(Cosentyx, COSENTYX)		[1] Secukinumab[1] Secukinumab (Cosentyx, COSENTYX) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 269 💬
11Secukinumab 150 MG/1 ML solution FOR injection
(Cosentyx, COSENTYX)		[1] Secukinumab[1] Secukinumab (Cosentyx, COSENTYX) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[2] 37, 271 💬
12Secukinumab 150 MG/ML
(Cosentyx, COSENTYX)		[1] Secukinumab[1] Secukinumab (Cosentyx, COSENTYX) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 271 💬
13Secukinumab 150MG
(Cosentyx, COSENTYX)		[1] Secukinumab[1] Secukinumab (Cosentyx, COSENTYX) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 37 💬
14Secukinumab 300 MG
(Cosentyx, COSENTYX)		[1] Secukinumab[1] Secukinumab (Cosentyx, COSENTYX) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 41 💬
15Secukinumab 300MG
(Cosentyx, COSENTYX)		[1] Secukinumab[1] Secukinumab (Cosentyx, COSENTYX) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 37 💬
16Secukinumab 75 MG/0.5 ML solution FOR injection
(Cosentyx, COSENTYX)		[1] Secukinumab[1] Secukinumab (Cosentyx, COSENTYX) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 271 💬
17Secukinumab injection
(Cosentyx, COSENTYX)		[1] Secukinumab[1] Secukinumab (Cosentyx, COSENTYX) 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 160 💬